1166 related articles for article (PubMed ID: 29874566)
1. Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States.
Mattson MP; Arumugam TV
Cell Metab; 2018 Jun; 27(6):1176-1199. PubMed ID: 29874566
[TBL] [Abstract][Full Text] [Related]
2. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.
Mattson MP; Pedersen WA; Duan W; Culmsee C; Camandola S
Ann N Y Acad Sci; 1999; 893():154-75. PubMed ID: 10672236
[TBL] [Abstract][Full Text] [Related]
3. Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance.
Raefsky SM; Mattson MP
Free Radic Biol Med; 2017 Jan; 102():203-216. PubMed ID: 27908782
[TBL] [Abstract][Full Text] [Related]
4. NAD
Lautrup S; Sinclair DA; Mattson MP; Fang EF
Cell Metab; 2019 Oct; 30(4):630-655. PubMed ID: 31577933
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits.
Mattson MP; Chan SL
J Mol Neurosci; 2001 Oct; 17(2):205-24. PubMed ID: 11816794
[TBL] [Abstract][Full Text] [Related]
6. Energy metabolism and inflammation in brain aging and Alzheimer's disease.
Yin F; Sancheti H; Patil I; Cadenas E
Free Radic Biol Med; 2016 Nov; 100():108-122. PubMed ID: 27154981
[TBL] [Abstract][Full Text] [Related]
7. Brain metabolism in health, aging, and neurodegeneration.
Camandola S; Mattson MP
EMBO J; 2017 Jun; 36(11):1474-1492. PubMed ID: 28438892
[TBL] [Abstract][Full Text] [Related]
8. The role of mitochondrial function in glutamate-dependent metabolism in neuronal cells.
Smaili SS; Ureshino RP; Rodrigues L; Rocha KK; Carvalho JT; Oseki KT; Bincoletto C; Lopes GS; Hirata H
Curr Pharm Des; 2011 Dec; 17(35):3865-77. PubMed ID: 21933141
[TBL] [Abstract][Full Text] [Related]
9. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
Beal MF
Ann Neurol; 1992 Feb; 31(2):119-30. PubMed ID: 1349466
[TBL] [Abstract][Full Text] [Related]
10. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
Belaidi AA; Bush AI
J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340
[TBL] [Abstract][Full Text] [Related]
11. Herbal/Natural Compounds Resist Hallmarks of Brain Aging: From Molecular Mechanisms to Therapeutic Strategies.
Qiao J; Wang C; Chen Y; Yu S; Liu Y; Yu S; Jiang L; Jin C; Wang X; Zhang P; Zhao D; Wang J; Liu M
Antioxidants (Basel); 2023 Apr; 12(4):. PubMed ID: 37107295
[TBL] [Abstract][Full Text] [Related]
12. A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events.
Heininger K
Rev Neurosci; 2000; 11 Spec No():213-328. PubMed ID: 11065271
[TBL] [Abstract][Full Text] [Related]
13. Calcium ions in neuronal degeneration.
Wojda U; Salinska E; Kuznicki J
IUBMB Life; 2008 Sep; 60(9):575-90. PubMed ID: 18478527
[TBL] [Abstract][Full Text] [Related]
14. The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics.
Di Domenico F; Barone E; Perluigi M; Butterfield DA
Antioxid Redox Signal; 2017 Mar; 26(8):364-387. PubMed ID: 27626216
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death.
Elstner M; Morris CM; Heim K; Bender A; Mehta D; Jaros E; Klopstock T; Meitinger T; Turnbull DM; Prokisch H
Acta Neuropathol; 2011 Jul; 122(1):75-86. PubMed ID: 21541762
[TBL] [Abstract][Full Text] [Related]
16. Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention.
Ding F; Yao J; Rettberg JR; Chen S; Brinton RD
PLoS One; 2013; 8(11):e79977. PubMed ID: 24244584
[TBL] [Abstract][Full Text] [Related]
17. Interventions that improve body and brain bioenergetics for Parkinson's disease risk reduction and therapy.
Mattson MP
J Parkinsons Dis; 2014; 4(1):1-13. PubMed ID: 24473219
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of neuronal death in brain aging and Alzheimer's disease: role of endocrine-mediated calcium dyshomeostasis.
Landfield PW; Thibault O; Mazzanti ML; Porter NM; Kerr DS
J Neurobiol; 1992 Nov; 23(9):1247-60. PubMed ID: 1469387
[TBL] [Abstract][Full Text] [Related]
19. Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection.
Zündorf G; Reiser G
Antioxid Redox Signal; 2011 Apr; 14(7):1275-88. PubMed ID: 20615073
[TBL] [Abstract][Full Text] [Related]
20. Αlpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease.
Bobela W; Aebischer P; Schneider BL
Biomolecules; 2015 Oct; 5(4):2675-700. PubMed ID: 26501339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
